HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Epigenetic reprogramming drives HCV liver cancer risk following DAA cure.
Source link
Epigenetic reprogramming drives HCV liver cancer risk following DAA cure.
Source link